Drug profile · INN
ferric citrate
AURYXIA
ferric citrate (AURYXIA) is a phosphate sequestering agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — ferric citrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
ferric citrate (AURYXIA) is a phosphate sequestering agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Phosphate sequestering agent
Primary target: Phosphate
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ferric citrate?
ferric citrate (AURYXIA) is a phosphate sequestering agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ferric citrate?
AURYXIA is a marketed brand name for ferric citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ferric citrate?
ferric citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.